FDA Approves Keytruda for Melanoma Patients After Tumor Resection
News
The U.S. Food and Drug Administration has approved the use of Keytruda (pembrolizumab) as a treatment for melanoma patients with stage 3 disease — cancer cells have spread to the lymph ... Read more